NO20024539L - Ny P-selektin glykoproteinligand (PSGL-1)-bindende protein og anvendelse derav - Google Patents

Ny P-selektin glykoproteinligand (PSGL-1)-bindende protein og anvendelse derav

Info

Publication number
NO20024539L
NO20024539L NO20024539A NO20024539A NO20024539L NO 20024539 L NO20024539 L NO 20024539L NO 20024539 A NO20024539 A NO 20024539A NO 20024539 A NO20024539 A NO 20024539A NO 20024539 L NO20024539 L NO 20024539L
Authority
NO
Norway
Prior art keywords
psgl
new
binding protein
glycoprotein ligand
selectin glycoprotein
Prior art date
Application number
NO20024539A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024539D0 (no
Inventor
Lorenz Melke
Roo Kriz
Nadine Weich
Gray D Shaw
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of NO20024539D0 publication Critical patent/NO20024539D0/no
Publication of NO20024539L publication Critical patent/NO20024539L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20024539A 2000-03-24 2002-09-20 Ny P-selektin glykoproteinligand (PSGL-1)-bindende protein og anvendelse derav NO20024539L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19210400P 2000-03-24 2000-03-24
PCT/US2001/009469 WO2001073028A2 (en) 2000-03-24 2001-03-23 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor

Publications (2)

Publication Number Publication Date
NO20024539D0 NO20024539D0 (no) 2002-09-20
NO20024539L true NO20024539L (no) 2002-11-21

Family

ID=22708261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024539A NO20024539L (no) 2000-03-24 2002-09-20 Ny P-selektin glykoproteinligand (PSGL-1)-bindende protein og anvendelse derav

Country Status (12)

Country Link
US (2) US6852497B2 (de)
EP (1) EP1274839A2 (de)
JP (1) JP2004507215A (de)
AU (2) AU2001249421B2 (de)
BR (1) BR0109524A (de)
CA (1) CA2404310A1 (de)
MX (1) MXPA02009271A (de)
NO (1) NO20024539L (de)
NZ (1) NZ521686A (de)
PL (1) PL362227A1 (de)
WO (1) WO2001073028A2 (de)
ZA (1) ZA200208406B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806739B1 (fr) 2000-03-27 2005-02-18 Fond Jean Dausset Ceph Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
RU2005101621A (ru) * 2002-07-01 2005-11-20 Савиент Фармасьютикалс, Инк. (Us) Антитела и их применения
AU2003255337A1 (en) * 2002-07-31 2004-02-23 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
WO2005047320A2 (en) * 2003-11-12 2005-05-26 Wisconsin Alumni Research Foundation Equine p-selection glycoprotein ligand-1 and uses thereof
US7807636B1 (en) 2004-11-12 2010-10-05 Wisconsin Alumni Research Foundation Bovine P-selectin glycorpotein ligand-1
US20070160601A1 (en) * 2005-12-09 2007-07-12 Angela Widom Neutralizing antibodies against primate psgl-1 and uses therefor
WO2007067983A2 (en) * 2005-12-09 2007-06-14 Wyeth Sulfotyrosine specific antibodies and uses therefor
US20120264212A1 (en) * 2009-11-06 2012-10-18 Virginia Tech Intellectual Properties, Inc. Compounds and methods for inhibiting the metastasis of cancer cells
KR20230132603A (ko) 2017-01-11 2023-09-15 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
JP7211961B2 (ja) 2017-03-14 2023-01-24 ファイヴ プライム セラピューティクス インク 酸性ｐＨでＶＩＳＴＡに結合する抗体
US11116833B2 (en) * 2018-02-08 2021-09-14 George Mason University Method and system for inactivating virus infectivity for producing live-attenuated vaccines
BR112021024242A2 (pt) * 2019-06-04 2022-04-26 Verseau Therapeutics Inc Composições e métodos anti-psgl-1 para modular fenótipos inflamatórios de células mieloides e usos dos mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
EP0666914B1 (de) 1992-10-23 2003-12-10 Genetics Institute, LLC Neuartiges p- selectin ligandenprotein
AU3774500A (en) * 1999-03-31 2000-10-16 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; "orfx"

Also Published As

Publication number Publication date
ZA200208406B (en) 2004-05-31
US6852497B2 (en) 2005-02-08
US7405272B2 (en) 2008-07-29
WO2001073028A3 (en) 2002-05-23
WO2001073028A2 (en) 2001-10-04
US20020037840A1 (en) 2002-03-28
NZ521686A (en) 2005-03-24
PL362227A1 (en) 2004-10-18
CA2404310A1 (en) 2001-10-04
EP1274839A2 (de) 2003-01-15
NO20024539D0 (no) 2002-09-20
AU4942101A (en) 2001-10-08
BR0109524A (pt) 2004-01-20
US20050152904A1 (en) 2005-07-14
JP2004507215A (ja) 2004-03-11
AU2001249421B2 (en) 2006-09-07
MXPA02009271A (es) 2003-03-12

Similar Documents

Publication Publication Date Title
DK1309692T3 (da) Anti-IL12-antistoffer, præparater, fremgangsmåder og anvendelser
DK1495053T3 (da) Angiopoietin-2 og angiopoietin-1-specifikke bindemidler
DK1307744T3 (da) Analyseapparat
DE69935419D1 (de) Zielorientierte benutzeroberfläche
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20004544L (no) Forbedret pumpeanordning og forbedrede fremgangsmÕter
NO20034405L (no) Anti-ostepontin-antistoff og anvendelse derav
GB0018682D0 (en) File analysis
DK1746375T3 (da) Oxygendrevet forbrændingssystem og anvendelser deraf
DK1131301T3 (da) 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
DK1278416T3 (da) Flydende præparater
DE60144464D1 (de) Probenentnehmer
NO20025158D0 (no) Lipidpreparat og anvendelse derav
NO20024539L (no) Ny P-selektin glykoproteinligand (PSGL-1)-bindende protein og anvendelse derav
ATE357211T1 (de) Dauerhaftes haarfrisurgel
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE10191532T1 (de) Probeentnahmevorrichtung
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
NO20020919D0 (no) Irenprotein, dets fremstilling og anvendelse
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
AT4039U3 (de) Abgas-probenbeutel
NO20025300L (no) Blodplatefunksjonsanalyse og reagenser for dette
ITMI20020432A1 (it) Procedimento e dispositivo per la legatura di libri in brossura
ITMI20011908A0 (it) Libro con segnalibro a nastro e procedimento per la sua fabbricazione

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application